Reprint

Crosstalk between Depression, Anxiety, Dementia, and Chronic Pain: Comorbidity in Behavioral Neurology and Neuropsychiatry 2.0

Edited by
August 2023
328 pages
  • ISBN978-3-0365-8253-5 (Hardback)
  • ISBN978-3-0365-8252-8 (PDF)

This book is a reprint of the Special Issue Crosstalk between Depression, Anxiety, Dementia, and Chronic Pain: Comorbidity in Behavioral Neurology and Neuropsychiatry 2.0 that was published in

Biology & Life Sciences
Medicine & Pharmacology
Summary

This Reprint is a compilation of recent studies published in the Special Issue titled, "Crosstalk between Depression, Anxiety, Dementia, and Chronic Pain: Comorbidity in Behavioral Neurology and Neuropsychiatry 2.0." This reprint explores the intricate nature of these common mental symptoms and their underlying mechanisms. It provides valuable insights into the coexistence of these conditions and their implications for behavioral neurology and neuropsychiatry. The reprint showcases cutting-edge research that reflects the dynamic and evolving nature of the field. The comprehensive coverage of the latest advancements in the reprint makes it an essential resource for researchers, clinicians, and practitioners seeking to stay informed about the recent progress in the field and gain insights into the potential of interdisciplinary research. To place an order for this Reprint, please visit the relevant website provided by MDPI.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
lipidomics; schizophrenia; animal models; antipsychotics; carnosine; cognitive function; depressive symptoms; age-related cognitive decline; Alzheimer’s disease; neuroinflammation; oxidative stress; depression; anxiety disorders; existential psychotherapy; logotherapy; meaning-centered psychotherapy; functional magnetic resonance imaging; biomarker; kynurenines; Martin Heidegger; Viktor Frankl; psychiatric disorder; machine learning; neural network; antipsychotics; schizophrenia; bipolar disorder; depression; precision medicine; endophenotype; decision making; survival; aging; Alzheimer’s disease; heterogeneity; long-life; gait analysis; cognition; BPSD; Alzheimer’s disease; genetic load; survival; end-of-life; frailty; heterogeneity; BPSD; NPS; neuro-immunoendocrine crosstalk; chronic inflammation; low-grade inflammation; immune tolerance; inflammatory factor; kynurenine; kynurenic acid; depression; bipolar disorder; substance use disorder; post-traumatic stress disorder; schizophrenia; autism spectrum disorder; RDoC; PI3K/Akt; signaling pathway; sex; genetic load; fine tuning; anxiety; aging; oscillations; anxiety; deep brain stimulation; electrophysiology; prefrontal; hippocampus; amygdala; chronic pain; nociceptive pain; neuropathic pain; nociplastic pain; psychogenic pain; neuroinflammation; kynurenine; chronic social defeat stress; anxiety; depression; lithium chloride; mice; ME/CFS heterogeneity; cytokines; intestinal permeability; tryptophan metabolism; kynurenine pathway; 3-hydroxykynurenine; kynurenine; serotonin; biomarkers; personalized medicine; animal model; behavior test; biomarker; blood–brain barrier; cognitive dysfunction; inflammation; memory dysfunction; neuronal cell death; Rho-associated protein kinase; vascular dementia; Alzheimer’s disease; aging; survival; anxious profile; functional profile; motor performance; frailty; training; gait; kyphosis; schizophrenia; vitamin D; anticholinergic drugs; antipsychotics; pharmacokinetics; cognition; processing speed; BACS; n/a